Xianglong Li

机构：Wenzhou Medical University, Jiangxi Science and Technology Normal University, Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Jiangxi Normal University · ORCID：0000-0002-7809-5981

发表论文 31 篇 · 总被引 406 次 · h-index 14

代表论文

• Copper‐Doped Polydopamine Nanoparticles‐Mediated GSH/GPX4‐Depleted Ferroptosis and Cuproptosis Sensitizes Lung Tumor to Checkpoint Blockade Immunotherapy (2025 · Small · 被引 34)
• Emerging glucose oxidase-delivering nanomedicines for enhanced tumor therapy (2025 · Journal of Controlled Release · 被引 34)
• Biomimic Binding Affinity Gradients Triggered GSH‐Response of Core–Shell Nanoparticles for Cascade Chemo/Chemodynamic Therapy (2021 · Advanced Healthcare Materials · 被引 34)
• GSH‐Responsive Organosilica Hybrid Nanosystem as a Cascade Promoter for Enhanced Starvation and Chemodynamic Therapy (2022 · Advanced Healthcare Materials · 被引 32)
• Engineering of a NIR-activable hydrogel-coated mesoporous bioactive glass scaffold with dual-mode parathyroid hormone derivative release property for angiogenesis and bone regeneration (2023 · Bioactive Materials · 被引 28)
• Glutathione degradable manganese-doped polydopamine nanoparticles for photothermal therapy and cGAS-STING activated immunotherapy of lung tumor (2024 · Journal of Colloid and Interface Science · 被引 24)